RCBTB2是RCC1蛋白超家族的一个成员。文献报道淋巴细胞性白血病和前列腺癌中13q14.2区域缺失，而该区域包含RCBTB2基因，推测RCBTB2可能是肿瘤抑制因子，但分子机制很不明确。我们前期研究发现在49%的肝癌中RCBTB2存在纯合/杂合型缺失，并伴随其mRNA及蛋白表达量下调；临床病理相关性分析发现RCBTB2低表达与肝癌不良分化相关；抑制RCBTB2影响初级纤毛形成并促进肝癌细胞生长。据此我们推测RCBTB2可能通过调控初级纤毛形成抑制肝癌细胞生长。本研究将以RCBTB2为中心，以RCBTB2与相关蛋白的相互作用和调节为主轴，利用酵母双杂交和蛋白组学技术发现新的RCBTB2相互作用因子；明确RCBTB2与互作因子参与调控细胞增殖的信号转导过程；采用分子、细胞、模式动物等方法阐明RCBTB2在肝癌发生中的作用及分子机制，发现新的分子靶点，为肝癌的分子诊断及靶向治疗提供理论依据。

RCBTB2 is a member of the RCC1 (Regulator of Chromosome Condensation 1) protein superfamily. It was reported that the chromosome region 13q14.2, within which RCBTB2 is located, is deleted in both B-cell chronic lymphocytic leukemia and prostate cancer, suggesting RCBTB2 as a tumor suppressor gene, with the molecular mechanism largely unknown. In our previous study, 49 percent of the examined liver cancer tissues present either homozygous or heterozygous loss of RCBTB2 gene, accompanied with reduction in the levels of both mRNA and protein. Furthermore, reduced RCBTB2 expression is correlated with poor differentiation of liver cancer, and suppression of the gene’s function results in defected primary cilium and promotes growth of tumor cell. Therefore we hypothesized that RCBTB2 can regulate tumorigenesis in liver, probably through its roles in primary cilium formation. In this study, focusing on RCBTB2 and its related proteins, we will utilize yeast two-hybrid and proteomics technology to identify novel proteins interacting with RCBTB2, and reveal the roles of RCBTB2 and its interacting proteins in signaling pathways regulating cell proliferation. Then through molecular biology methods and model mice , we will clarify the functions of RCBTB2 in tumorigenesis of liver cancer and the associated mechanisms, and finally discover a novel molecular target for both diagnosis and targeted therapy for liver cancer.